$ABT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABBOTT LABORATORIES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ABBOTT LABORATORIES. Get notifications about new insider transactions in ABBOTT LABORATORIES for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 53 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Option Exercise | A | 75.90 | 151,933 | 11,531,715 | 151,933 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Grant | A | 0.00 | 28,985 | 0 | 163,099 | 134.1 K to 163.1 K (+21.61 %) |
Feb 20 2019 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Payment of Exercise | F | 75.25 | 505 | 38,001 | 71,918 | 72.4 K to 71.9 K (-0.70 %) |
Feb 20 2019 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Payment of Exercise | F | 75.25 | 450 | 33,863 | 72,423 | 72.9 K to 72.4 K (-0.62 %) |
Feb 20 2019 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Payment of Exercise | F | 75.25 | 710 | 53,428 | 8,356 | 9.1 K to 8.4 K (-7.83 %) |
Feb 20 2019 | ABT | ABBOTT LABORATORIE ... | Karam Sammy | Senior Vice Preside ... | Payment of Exercise | F | 75.25 | 792 | 59,598 | 16,290 | 17.1 K to 16.3 K (-4.64 %) |
Feb 20 2019 | ABT | ABBOTT LABORATORIE ... | Karam Sammy | Senior Vice Preside ... | Payment of Exercise | F | 75.25 | 771 | 58,018 | 17,082 | 17.9 K to 17.1 K (-4.32 %) |
Feb 20 2019 | ABT | ABBOTT LABORATORIE ... | Karam Sammy | Senior Vice Preside ... | Payment of Exercise | F | 75.25 | 814 | 61,254 | 17,853 | 18.7 K to 17.9 K (-4.36 %) |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 38.40 | 77,550 | 2,977,920 | 80,860 | |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 47.00 | 62,600 | 2,942,200 | 0 | |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 47.00 | 83,951 | 3,945,697 | 62,600 | |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 38.40 | 84,169 | 3,232,090 | 158,410 | |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 44.40 | 46,017 | 2,043,155 | 92,032 | |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Payment of Exercise | F | 71.68 | 108,090 | 7,747,891 | 111,301 | 219.4 K to 111.3 K (-49.27 %) |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 38.40 | 77,550 | 2,977,920 | 231,798 | 154.2 K to 231.8 K (+50.28 %) |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 47.00 | 62,600 | 2,942,200 | 154,248 | 91.6 K to 154.2 K (+68.30 %) |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 70.00 | 177,457 | 12,421,990 | 91,648 | 269.1 K to 91.6 K (-65.94 %) |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 47.00 | 83,951 | 3,945,697 | 269,105 | 185.2 K to 269.1 K (+45.34 %) |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 38.40 | 84,169 | 3,232,090 | 185,154 | 101 K to 185.2 K (+83.35 %) |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 44.40 | 46,017 | 2,043,155 | 100,985 | 55 K to 101 K (+83.72 %) |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Buy | P | 72.32 | 100 | 7,232 | 6,400 | 6.3 K to 6.4 K (+1.59 %) |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Buy | P | 72.31 | 100 | 7,231 | 6,300 | 6.2 K to 6.3 K (+1.61 %) |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Buy | P | 72.33 | 1,800 | 130,194 | 6,200 | 4.4 K to 6.2 K (+40.91 %) |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Buy | P | 72.32 | 842 | 60,893 | 4,400 | 3.6 K to 4.4 K (+23.66 %) |
Feb 01 2019 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Buy | P | 72.31 | 613 | 44,326 | 3,558 | 2.9 K to 3.6 K (+20.81 %) |
Jan 03 2019 | ABT | ABBOTT LABORATORIE ... | Shrimpton Sean | Senior Vice Preside ... | Payment of Exercise | F | 71.09 | 481 | 34,194 | 16,165 | 16.6 K to 16.2 K (-2.89 %) |
Dec 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Gift | G | 0.00 | 60 | 0 | 133,158 | 133.2 K to 133.2 K (-0.05 %) |
Dec 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Gift | G | 0.00 | 3,600 | 0 | 133,218 | 136.8 K to 133.2 K (-2.63 %) |
Dec 21 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Gift | G | 0.00 | 642 | 0 | 0 | 642 to 0 (-100.00 %) |
Dec 21 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Gift | G | 0.00 | 642 | 0 | 642 | 0 to 642 |
Dec 21 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Gift | G | 0.00 | 6,071 | 0 | 3,126,830 | 3.1 M to 3.1 M (-0.19 %) |
Dec 21 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Gift | G | 0.00 | 1,284 | 0 | 3,132,901 | 3.1 M to 3.1 M (-0.04 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.60 | 119 | 8,639 | 3,134,185 | 3.1 M to 3.1 M (0.00 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.59 | 500 | 36,295 | 3,134,304 | 3.1 M to 3.1 M (-0.02 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.59 | 2,900 | 210,497 | 3,134,804 | 3.1 M to 3.1 M (-0.09 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.58 | 400 | 29,032 | 3,137,704 | 3.1 M to 3.1 M (-0.01 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.58 | 1,600 | 116,120 | 3,138,104 | 3.1 M to 3.1 M (-0.05 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.57 | 100 | 7,257 | 3,139,704 | 3.1 M to 3.1 M (0.00 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.57 | 100 | 7,257 | 3,139,804 | 3.1 M to 3.1 M (0.00 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.55 | 1,100 | 79,800 | 3,139,904 | 3.1 M to 3.1 M (-0.04 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.54 | 600 | 43,524 | 3,141,004 | 3.1 M to 3.1 M (-0.02 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.54 | 1,620 | 117,507 | 3,141,604 | 3.1 M to 3.1 M (-0.05 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.53 | 8,300 | 601,999 | 3,143,224 | 3.2 M to 3.1 M (-0.26 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.53 | 130 | 9,429 | 3,151,524 | 3.2 M to 3.2 M (0.00 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.53 | 11,945 | 866,311 | 3,151,654 | 3.2 M to 3.2 M (-0.38 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.52 | 5,400 | 391,608 | 3,163,599 | 3.2 M to 3.2 M (-0.17 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.52 | 64,374 | 4,668,081 | 3,168,999 | 3.2 M to 3.2 M (-1.99 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.51 | 1,961 | 142,192 | 3,233,373 | 3.2 M to 3.2 M (-0.06 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.51 | 3,859 | 279,797 | 3,235,334 | 3.2 M to 3.2 M (-0.12 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.50 | 4,700 | 340,750 | 3,239,193 | 3.2 M to 3.2 M (-0.14 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.50 | 12,683 | 919,454 | 3,243,893 | 3.3 M to 3.2 M (-0.39 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.49 | 1,400 | 101,486 | 3,256,576 | 3.3 M to 3.3 M (-0.04 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.49 | 7,463 | 540,956 | 3,257,976 | 3.3 M to 3.3 M (-0.23 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.48 | 900 | 65,232 | 3,265,439 | 3.3 M to 3.3 M (-0.03 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.48 | 61 | 4,421 | 3,266,339 | 3.3 M to 3.3 M (0.00 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.47 | 518 | 37,537 | 3,266,400 | 3.3 M to 3.3 M (-0.02 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.46 | 210 | 15,217 | 3,266,918 | 3.3 M to 3.3 M (-0.01 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.46 | 5,147 | 372,926 | 3,267,128 | 3.3 M to 3.3 M (-0.16 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.45 | 3,000 | 217,350 | 3,272,275 | 3.3 M to 3.3 M (-0.09 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.45 | 1,800 | 130,401 | 3,275,275 | 3.3 M to 3.3 M (-0.05 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.44 | 856 | 62,009 | 3,277,075 | 3.3 M to 3.3 M (-0.03 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.44 | 3,401 | 246,351 | 3,277,931 | 3.3 M to 3.3 M (-0.10 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.43 | 6,600 | 478,038 | 3,281,332 | 3.3 M to 3.3 M (-0.20 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.43 | 5,716 | 413,981 | 3,287,932 | 3.3 M to 3.3 M (-0.17 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.42 | 5,674 | 410,911 | 3,293,648 | 3.3 M to 3.3 M (-0.17 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.42 | 10,177 | 736,967 | 3,299,322 | 3.3 M to 3.3 M (-0.31 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.41 | 7,345 | 531,851 | 3,309,499 | 3.3 M to 3.3 M (-0.22 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Option Exercise | M | 26.02 | 325,000 | 8,454,875 | 0 | |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.41 | 12,538 | 907,814 | 3,316,844 | 3.3 M to 3.3 M (-0.38 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.40 | 13,564 | 982,034 | 3,329,382 | 3.3 M to 3.3 M (-0.41 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.40 | 10,022 | 725,543 | 3,342,946 | 3.4 M to 3.3 M (-0.30 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.39 | 3,100 | 224,409 | 3,352,968 | 3.4 M to 3.4 M (-0.09 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.39 | 5,462 | 395,367 | 3,356,068 | 3.4 M to 3.4 M (-0.16 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.38 | 5,200 | 376,376 | 3,361,530 | 3.4 M to 3.4 M (-0.15 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.38 | 1,761 | 127,452 | 3,366,730 | 3.4 M to 3.4 M (-0.05 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.37 | 1,916 | 138,661 | 3,368,491 | 3.4 M to 3.4 M (-0.06 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.37 | 3,008 | 217,674 | 3,370,407 | 3.4 M to 3.4 M (-0.09 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.36 | 3,800 | 274,968 | 3,373,415 | 3.4 M to 3.4 M (-0.11 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.36 | 7,181 | 519,581 | 3,377,215 | 3.4 M to 3.4 M (-0.21 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.35 | 4,250 | 307,488 | 3,384,396 | 3.4 M to 3.4 M (-0.13 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.35 | 14,290 | 1,033,810 | 3,388,646 | 3.4 M to 3.4 M (-0.42 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.34 | 6,825 | 493,721 | 3,402,936 | 3.4 M to 3.4 M (-0.20 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.34 | 3,460 | 250,279 | 3,409,761 | 3.4 M to 3.4 M (-0.10 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.33 | 1,595 | 115,366 | 3,413,221 | 3.4 M to 3.4 M (-0.05 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.33 | 6,945 | 502,297 | 3,414,816 | 3.4 M to 3.4 M (-0.20 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.32 | 5,100 | 368,832 | 3,421,761 | 3.4 M to 3.4 M (-0.15 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.32 | 2,300 | 166,325 | 3,426,861 | 3.4 M to 3.4 M (-0.07 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.31 | 4,385 | 317,079 | 3,429,161 | 3.4 M to 3.4 M (-0.13 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.31 | 10,757 | 777,785 | 3,433,546 | 3.4 M to 3.4 M (-0.31 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.30 | 1,381 | 99,846 | 3,444,303 | 3.4 M to 3.4 M (-0.04 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.30 | 1,327 | 95,935 | 3,445,684 | 3.4 M to 3.4 M (-0.04 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.29 | 2,102 | 151,954 | 3,447,011 | 3.4 M to 3.4 M (-0.06 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.29 | 231 | 16,698 | 3,449,113 | 3.4 M to 3.4 M (-0.01 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.29 | 4,870 | 352,028 | 3,449,344 | 3.5 M to 3.4 M (-0.14 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.28 | 2,771 | 200,288 | 3,454,214 | 3.5 M to 3.5 M (-0.08 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.28 | 1,400 | 101,185 | 3,456,985 | 3.5 M to 3.5 M (-0.04 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 72.27 | 800 | 57,816 | 3,458,385 | 3.5 M to 3.5 M (-0.02 %) |
Nov 30 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Buy | M | 26.02 | 325,000 | 8,454,875 | 3,459,185 | 3.1 M to 3.5 M (+10.37 %) |
Nov 06 2018 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Option Exercise | M | 38.40 | 65,000 | 2,496,000 | 109,657 | |
Nov 06 2018 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Sell | S | 71.00 | 65,000 | 4,615,000 | 63,640 | 128.6 K to 63.6 K (-50.53 %) |
Nov 06 2018 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Buy | M | 38.40 | 65,000 | 2,496,000 | 128,640 | 63.6 K to 128.6 K (+102.14 %) |
Oct 02 2018 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Option Exercise | A | 0.00 | 429 | 0 | 2,639 | |
Oct 02 2018 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 107 | 0 | 7,133 | |
Oct 02 2018 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 73.36 | 100 | 7,336 | 39,029 | 39.1 K to 39 K (-0.26 %) |
Oct 02 2018 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 73.35 | 100 | 7,335 | 39,129 | 39.2 K to 39.1 K (-0.25 %) |
Oct 02 2018 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 73.35 | 1,532 | 112,374 | 39,229 | 40.8 K to 39.2 K (-3.76 %) |
Oct 02 2018 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 73.39 | 4,800 | 352,277 | 88,521 | 93.3 K to 88.5 K (-5.14 %) |
Oct 02 2018 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 73.40 | 200 | 14,680 | 93,321 | 93.5 K to 93.3 K (-0.21 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | M | 29.29 | 10,100 | 295,849 | 0 | |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | M | 27.03 | 48,100 | 1,300,316 | 0 | |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.85 | 100 | 6,885 | 136,818 | 136.9 K to 136.8 K (-0.07 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.84 | 3,214 | 221,252 | 136,918 | 140.1 K to 136.9 K (-2.29 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.84 | 960 | 66,082 | 140,132 | 141.1 K to 140.1 K (-0.68 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.83 | 6,240 | 429,499 | 141,092 | 147.3 K to 141.1 K (-4.24 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.83 | 2,000 | 137,650 | 147,332 | 149.3 K to 147.3 K (-1.34 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.82 | 5,800 | 399,156 | 149,332 | 155.1 K to 149.3 K (-3.74 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.82 | 1,136 | 78,174 | 155,132 | 156.3 K to 155.1 K (-0.73 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.81 | 4,522 | 311,159 | 156,268 | 160.8 K to 156.3 K (-2.81 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.81 | 1,442 | 99,217 | 160,790 | 162.2 K to 160.8 K (-0.89 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.80 | 1,500 | 103,200 | 162,232 | 163.7 K to 162.2 K (-0.92 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.80 | 1,100 | 75,675 | 163,732 | 164.8 K to 163.7 K (-0.67 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.79 | 7,807 | 537,044 | 164,832 | 172.6 K to 164.8 K (-4.52 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.79 | 2,300 | 158,206 | 172,639 | 174.9 K to 172.6 K (-1.31 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.78 | 2,400 | 165,072 | 174,939 | 177.3 K to 174.9 K (-1.35 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.78 | 3,822 | 262,858 | 177,339 | 181.2 K to 177.3 K (-2.11 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.77 | 3,020 | 207,685 | 181,161 | 184.2 K to 181.2 K (-1.64 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.77 | 1,837 | 126,321 | 184,181 | 186 K to 184.2 K (-0.99 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.76 | 1,757 | 120,811 | 186,018 | 187.8 K to 186 K (-0.94 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.76 | 2,043 | 140,466 | 187,775 | 189.8 K to 187.8 K (-1.08 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.75 | 800 | 55,000 | 189,818 | 190.6 K to 189.8 K (-0.42 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.75 | 1,250 | 85,931 | 190,618 | 191.9 K to 190.6 K (-0.65 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.74 | 1,800 | 123,732 | 191,868 | 193.7 K to 191.9 K (-0.93 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.74 | 100 | 6,874 | 193,668 | 193.8 K to 193.7 K (-0.05 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.74 | 350 | 24,057 | 193,768 | 194.1 K to 193.8 K (-0.18 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 68.73 | 900 | 61,857 | 194,118 | 195 K to 194.1 K (-0.46 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | M | 29.29 | 10,100 | 295,849 | 195,018 | 184.9 K to 195 K (+5.46 %) |
Sep 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | M | 27.03 | 48,100 | 1,300,316 | 184,918 | 136.8 K to 184.9 K (+35.16 %) |
Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Option Exercise | M | 27.03 | 14,400 | 389,284 | 0 | |
Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Option Exercise | M | 22.39 | 12,300 | 275,420 | 0 | |
Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Option Exercise | M | 26.19 | 9,700 | 254,023 | 0 | |
Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Payment of Exercise | F | 67.11 | 23,751 | 1,593,930 | 121,329 | 145.1 K to 121.3 K (-16.37 %) |
Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Buy | M | 27.03 | 14,400 | 389,284 | 145,080 | 130.7 K to 145.1 K (+11.02 %) |
Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Buy | M | 22.39 | 12,300 | 275,420 | 130,680 | 118.4 K to 130.7 K (+10.39 %) |
Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Buy | M | 26.19 | 9,700 | 254,023 | 118,380 | 108.7 K to 118.4 K (+8.93 %) |
Aug 31 2018 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 66.87 | 10,200 | 682,074 | 54,968 | 65.2 K to 55 K (-15.65 %) |
Aug 31 2018 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 66.87 | 474 | 31,694 | 73,043 | 73.5 K to 73 K (-0.64 %) |
Aug 31 2018 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 66.86 | 14,800 | 989,528 | 73,517 | 88.3 K to 73.5 K (-16.76 %) |
Aug 31 2018 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 66.86 | 840 | 56,158 | 88,317 | 89.2 K to 88.3 K (-0.94 %) |
Aug 31 2018 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 66.85 | 8,335 | 557,195 | 89,157 | 97.5 K to 89.2 K (-8.55 %) |
Aug 31 2018 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 66.85 | 805 | 53,810 | 97,492 | 98.3 K to 97.5 K (-0.82 %) |